IASO Biotherapeutics
Focused on the discovery, development and commercialization of cell therapies in the field of oncology.
Launch date
Employees
Market cap
-
Enterprise valuation
€491m (Public information from Jan 2023)
Jiangsu China (HQ), Nanjing China (HQ)
Authorizing premium user...